3DVT
| |
3DVH
| LC8 Point mutant K36P | Descriptor: | Dynein light chain 1, cytoplasmic | Authors: | Lightcap, C.M, Williams, J.C. | Deposit date: | 2008-07-18 | Release date: | 2009-01-20 | Last modified: | 2023-08-30 | Method: | X-RAY DIFFRACTION (2 Å) | Cite: | Biochemical and structural characterization of the Pak1-LC8 interaction. J.Biol.Chem., 283, 2008
|
|
3DVP
| Pak1 peptide bound LC8 | Descriptor: | Dynein light chain 1, cytoplasmic, P21 activated Kinase peptide | Authors: | Lightcap, C.M, Williams, J.C. | Deposit date: | 2008-07-18 | Release date: | 2009-01-20 | Last modified: | 2024-02-21 | Method: | X-RAY DIFFRACTION (2.5 Å) | Cite: | Biochemical and structural characterization of the Pak1-LC8 interaction. J.Biol.Chem., 283, 2008
|
|
4HKZ
| Trastuzumab Fab complexed with Protein L and Protein A fragments | Descriptor: | CHLORIDE ION, Immunoglobulin G-binding protein A, Protein L fragment, ... | Authors: | Avery, K.N, Zer, C, Bzymek, K.P, Williams, J.C. | Deposit date: | 2012-10-15 | Release date: | 2013-10-09 | Last modified: | 2017-11-15 | Method: | X-RAY DIFFRACTION (2.08 Å) | Cite: | Identification and grafting of a unique peptide-binding site in the Fab framework of monoclonal antibodies. Proc.Natl.Acad.Sci.USA, 110, 2013
|
|
4GW5
| cQYN meditope - Cetuximab Fab | Descriptor: | Fab Heavy Chain, Fab Light Chain, PHOSPHATE ION, ... | Authors: | Donaldson, J.M, Zer, C, Avery, K.N, Bzymek, K.P, Horne, D.A, Williams, J.C. | Deposit date: | 2012-08-31 | Release date: | 2013-10-09 | Last modified: | 2023-09-13 | Method: | X-RAY DIFFRACTION (2.2 Å) | Cite: | Identification and grafting of a unique peptide-binding site in the Fab framework of monoclonal antibodies. Proc.Natl.Acad.Sci.USA, 110, 2013
|
|
4HJG
| Meditope-enabled trastuzumab | Descriptor: | Immunoglobulin G-binding protein A, Protein L fragment, Trastuzumab heavy chain, ... | Authors: | Donaldson, J.M, Zer, C, Avery, K.N, Bzymek, K.P, Horne, D.A, Williams, J.C. | Deposit date: | 2012-10-12 | Release date: | 2013-10-09 | Last modified: | 2024-10-30 | Method: | X-RAY DIFFRACTION (2 Å) | Cite: | Identification and grafting of a unique peptide-binding site in the Fab framework of monoclonal antibodies. Proc.Natl.Acad.Sci.USA, 110, 2013
|
|
5TH2
| Cetuximab Fab in complex with L5Q meditope variant | Descriptor: | L5Q meditope, PHOSPHATE ION, cetuximab Fab, ... | Authors: | Bzymek, K.P, Williams, J.C. | Deposit date: | 2016-09-28 | Release date: | 2016-10-26 | Last modified: | 2024-10-30 | Method: | X-RAY DIFFRACTION (1.84 Å) | Cite: | Natural and non-natural amino-acid side-chain substitutions: affinity and diffraction studies of meditope-Fab complexes. Acta Crystallogr F Struct Biol Commun, 72, 2016
|
|
5U5F
| MEDITOPE ENABLED TRASTUZUMAB I83E VARIANT IN COMPLEX WITH (Ac) CQFDA(PH)2STRRLRCGGSK | Descriptor: | 5-DIPHENYL LONG MEDITOPE, Immunoglobulin G binding protein A, MEMAB TRASTUZUMAB FAB HEAVY CHAIN, ... | Authors: | Bzymek, K.P, Avery, K.N, Zer, C, Williams, J.C. | Deposit date: | 2016-12-06 | Release date: | 2018-03-14 | Last modified: | 2023-11-15 | Method: | X-RAY DIFFRACTION (1.81 Å) | Cite: | Meditope Enabled Trastuzumab I83E Variant In Complex With (Ac)Cqfda(Ph)2Strrlrcggsk To Be Published
|
|
5T1L
| Cetuximab Fab in complex with CQA(Ph)2DLSTRRLKC peptide | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, CETUXIMAB FAB HEAVY CHAIN, CETUXIMAB FAB LIGHT CHAIN, ... | Authors: | Bzymek, K.P, Williams, J.C. | Deposit date: | 2016-08-19 | Release date: | 2016-10-26 | Last modified: | 2023-11-15 | Method: | X-RAY DIFFRACTION (2.48 Å) | Cite: | Natural and non-natural amino-acid side-chain substitutions: affinity and diffraction studies of meditope-Fab complexes. Acta Crystallogr F Struct Biol Commun, 72, 2016
|
|
5U3D
| STRUCTURE OF MEDITOPE ENABLED TRASTUZUMAB I83E VARIANT | Descriptor: | Immunoglobulin G binding protein A, MEMAB TRASTUZUMAB FAB HEAVY CHAIN, MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E, ... | Authors: | Bzymek, K.P, Avery, K.N, Zer, C, Williams, J.C. | Deposit date: | 2016-12-01 | Release date: | 2018-03-14 | Last modified: | 2024-10-30 | Method: | X-RAY DIFFRACTION (1.77 Å) | Cite: | Meditope Enabled Trastuzumab I83E Variant To Be Published
|
|
2MPX
| |
5ESQ
| Cetuximab Fab in complex with cyclic beta-alanine-linked meditope | Descriptor: | Cetuximab Fab heavy chain, Cetuximab Fab light chain, Cyclic beta-alanine-linked meditope, ... | Authors: | Bzymek, K.P, Williams, J.C. | Deposit date: | 2015-11-16 | Release date: | 2016-06-15 | Last modified: | 2017-12-13 | Method: | X-RAY DIFFRACTION (2.55 Å) | Cite: | Cyclization strategies of meditopes: affinity and diffraction studies of meditope-Fab complexes. Acta Crystallogr F Struct Biol Commun, 72, 2016
|
|
5ETU
| Cetuximab Fab in complex with L5E meditope variant | Descriptor: | Cetuximab Fab heavy chain, Cetuximab Fab light chain, L5E meditope variant, ... | Authors: | Bzymek, K.P, Williams, J.C. | Deposit date: | 2015-11-18 | Release date: | 2016-10-26 | Last modified: | 2023-09-27 | Method: | X-RAY DIFFRACTION (2.53 Å) | Cite: | Natural and non-natural amino-acid side-chain substitutions: affinity and diffraction studies of meditope-Fab complexes. Acta Crystallogr F Struct Biol Commun, 72, 2016
|
|
5EUK
| Cetuximab Fab in complex with F3H meditope variant | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, Cetuximab Fab heavy chain, Cetuximab Fab light chain, ... | Authors: | Bzymek, K.P, Williams, J.C. | Deposit date: | 2015-11-18 | Release date: | 2016-10-26 | Last modified: | 2023-09-27 | Method: | X-RAY DIFFRACTION (2.5 Å) | Cite: | Natural and non-natural amino-acid side-chain substitutions: affinity and diffraction studies of meditope-Fab complexes. Acta Crystallogr F Struct Biol Commun, 72, 2016
|
|
5T1K
| Cetuximab Fab in complex with CQFDA(Ph)2STRRLKC | Descriptor: | CETUXIMAB FAB HEAVY CHAIN, CETUXIMAB FAB LIGHT CHAIN, CQFDA(PH)2STRRLKC PEPTIDE, ... | Authors: | Bzymek, K.P, Williams, J.C. | Deposit date: | 2016-08-19 | Release date: | 2016-10-26 | Last modified: | 2023-11-15 | Method: | X-RAY DIFFRACTION (2.48 Å) | Cite: | Natural and non-natural amino-acid side-chain substitutions: affinity and diffraction studies of meditope-Fab complexes. Acta Crystallogr F Struct Biol Commun, 72, 2016
|
|
5T1M
| Cetuximab Fab in complex with CQYDLSTRRLKC | Descriptor: | 2-acetamido-2-deoxy-beta-D-glucopyranose, CETUXIMAB FAB HEAVY CHAIN, CETUXIMAB FAB LIGHT CHAIN, ... | Authors: | Bzymek, K.P, Williams, J.C. | Deposit date: | 2016-08-19 | Release date: | 2016-10-26 | Last modified: | 2024-10-16 | Method: | X-RAY DIFFRACTION (2.53 Å) | Cite: | Natural and non-natural amino-acid side-chain substitutions: affinity and diffraction studies of meditope-Fab complexes. Acta Crystallogr F Struct Biol Commun, 72, 2016
|
|
7JKM
| |